EQPT enters the back half of June with a striking collision of signals: the lending market has tightened to its tightest point in a year, founders are buying the stock with their own money, and options traders have swung decisively bullish — all while the stock dropped 8% in a single session on Tuesday.
The lending story is the most urgent development. Availability collapsed to just 1.4% on June 23 — down from 27% only the day before, and a fraction of the 42%-plus levels seen for most of the prior two weeks. That means nearly every share in the lending pool is currently out on loan, the tightest the borrow market has been in at least a year. Cost to borrow has eased significantly from the 5%-plus spikes seen in mid-May, now running near 1.5%, but the sudden availability squeeze tells a more important story: demand for borrowed shares jumped sharply this week, almost certainly fuelled by the 8% single-day selloff on June 23. Short interest itself has been building quietly — up around 16% over the past month to roughly 15.8 million shares — though without a free-float percentage available, the absolute level is harder to contextualise. What the borrow data makes clear is that whoever wanted to add short exposure into Tuesday's drop found very little room left in the lending pool to do so.
Options positioning contradicts the bearish borrow signal directly. The put/call ratio has fallen to 0.49, well below its 20-day average of 0.68 and about 1.2 standard deviations on the bullish side of normal. The contrast with late May is stark: the PCR touched a 52-week high of 2.02 on May 18, reflecting heavy demand for downside protection. That protective posture has almost entirely unwound. Call open interest is dominant right now, suggesting that options traders — at least those who haven't already paid up for hedges — are positioned for recovery rather than further decline.
The founders are not standing aside. On June 15, both the company's Founder/President and Founder/CEO purchased stock in the open market, together spending roughly $2.1 million at prices between $20.83 and $21.50. A director bought another $499,000 at $22.89 in May. Net insider buying across the past 90 days totals approximately $2.9 million across 131,803 shares — a cluster of conviction purchases that preceded and now sits below Tuesday's close of $23.88. The Founder/CEO buys are particularly notable: insiders with full visibility on the business chose to add at prices the stock is now trading above, even after a sharp single-day drop.
The Street's read is mixed but tilts constructive. Most analysts covering EQPT hold positive ratings. Truist Securities maintained a Buy with a $41 target and Citizens reiterated Market Outperform at $42 as recently as June 22 — the day before the selloff. Citigroup is the outlier, holding a Neutral with a $26 target after raising it from $22 in May. The consensus mean target is $39, implying meaningful upside from current levels, though the Citi target sitting close to the stock price reflects genuine disagreement about valuation. Bulls point to rental revenue growth, technology platform differentiation, and expanding organic capacity. Bears flag net debt levels and rate sensitivity. The ORTEX short score has edged up to 77.3 — a high reading that reflects the combination of tightening borrow availability and rising short shares, a signal worth watching if availability stays near zero.
The next scheduled catalyst is the August 12 earnings report. Reaction history at prior prints has been uneven: the stock fell 3.2% the day after the June 2026 report and dropped 6.4% following the May 2026 result, though one earlier print produced a 3.8% gain. With the borrow market now fully used, any sharp move higher from short covering would face a lending pool with almost no room to accommodate new entries — the setup heading into August will depend heavily on whether availability rebuilds or stays locked down through the summer.
See the live data behind this article on ORTEX.
Open EQPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
EQPT enters its first earnings call as a public company with a striking contradiction: the stock has surged 27% in a week, yet short sellers have been building positions at the fastest pace since its IPO. Short…
Short sellers are pressing hard into EQPT ahead of its earnings release. Cost to borrow has nearly doubled in one week — and short shares are up 24% over the same period. CTB hit 2.16% on May 12, up 93% in seven days.…
